PL2012773T3 - Leki i zastosowania - Google Patents

Leki i zastosowania

Info

Publication number
PL2012773T3
PL2012773T3 PL07863339T PL07863339T PL2012773T3 PL 2012773 T3 PL2012773 T3 PL 2012773T3 PL 07863339 T PL07863339 T PL 07863339T PL 07863339 T PL07863339 T PL 07863339T PL 2012773 T3 PL2012773 T3 PL 2012773T3
Authority
PL
Poland
Prior art keywords
drugs
Prior art date
Application number
PL07863339T
Other languages
English (en)
Inventor
James M Frincke
Christopher L Reading
Original Assignee
Harbor Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harbor Biosciences Inc filed Critical Harbor Biosciences Inc
Publication of PL2012773T3 publication Critical patent/PL2012773T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL07863339T 2006-04-22 2007-04-23 Leki i zastosowania PL2012773T3 (pl)

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
US79379206P 2006-04-22 2006-04-22
US84311206P 2006-09-08 2006-09-08
US82556906P 2006-09-13 2006-09-13
US82556406P 2006-09-13 2006-09-13
US82984806P 2006-10-17 2006-10-17
US86639506P 2006-11-17 2006-11-17
US86670006P 2006-11-21 2006-11-21
US86804206P 2006-11-30 2006-11-30
US88500307P 2007-01-15 2007-01-15
US88805807P 2007-02-02 2007-02-02
PCT/US2007/067235 WO2008039566A2 (en) 2006-04-22 2007-04-23 Drugs and uses
EP07863339A EP2012773B1 (en) 2006-04-22 2007-04-23 Drugs and uses

Publications (1)

Publication Number Publication Date
PL2012773T3 true PL2012773T3 (pl) 2012-12-31

Family

ID=39230844

Family Applications (2)

Application Number Title Priority Date Filing Date
PL07863339T PL2012773T3 (pl) 2006-04-22 2007-04-23 Leki i zastosowania
PL12167186T PL2486924T3 (pl) 2006-04-22 2007-04-23 Leki i zastosowania

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL12167186T PL2486924T3 (pl) 2006-04-22 2007-04-23 Leki i zastosowania

Country Status (13)

Country Link
EP (2) EP2012773B1 (pl)
JP (2) JP5130591B2 (pl)
KR (1) KR20080112413A (pl)
CN (1) CN103211821A (pl)
AU (2) AU2007300404B2 (pl)
CA (1) CA2649940C (pl)
DK (2) DK2486924T3 (pl)
EA (1) EA200802167A1 (pl)
ES (2) ES2389743T3 (pl)
HU (1) HUE042925T2 (pl)
IL (1) IL194751A0 (pl)
PL (2) PL2012773T3 (pl)
WO (1) WO2008039566A2 (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8569275B2 (en) 2002-08-28 2013-10-29 Harbor Therapeutics, Inc. Steroids having 7-oxgen and 17-heteroaryl substitution
US8486926B2 (en) 2006-11-17 2013-07-16 Harbor Therapeutics, Inc. Steroid tetrol solid state forms
US8217025B2 (en) 2006-11-17 2012-07-10 Harbor Therapeutics, Inc. Drug screening and treatment methods
US8354396B2 (en) 2006-11-17 2013-01-15 Harbor Therapeutics, Inc. Drug identification and treatment method
EA018974B9 (ru) * 2008-02-05 2014-04-30 Харбор Терапьютикс, Инк. Твердые лекарственные формы
AU2009231589B2 (en) 2008-04-03 2013-11-07 Neurmedix, Inc. Solid state forms of a pharmaceutical
PL2300489T3 (pl) * 2008-06-06 2016-11-30 Sposoby wytwarzania 17-alkinylo-7-hydroksysteroidów i związków pokrewnych
WO2011156673A2 (en) * 2010-06-10 2011-12-15 Isis Pharmaceuticals, Inc. Modulation of phosphoenolpyruvate carboxykinase-mitochondrial (pepck-m) expression
WO2012083201A1 (en) * 2010-12-17 2012-06-21 Harbor Biosciences, Inc. Steroid tetrol solid state forms-2
CN113956315B (zh) * 2011-09-08 2024-08-09 萨奇治疗股份有限公司 神经活性类固醇、组合物、及其用途
ITMI20121472A1 (it) * 2012-09-04 2014-03-05 Ind Chimica Srl Processo per la preparazione di 11-metilen-18-metilestr-4-en-3,17-dione, utile come intermedio per la sintesi di molecole ad attivita' farmacologica
KR101687061B1 (ko) * 2014-02-25 2016-12-16 순천향대학교 산학협력단 나이에 따른 당뇨병 진단을 위한 글루코코르티코이드 수용체의 검출제제를 포함하는 타입 2 당뇨 진단 키트
CN105017361A (zh) * 2015-07-16 2015-11-04 湖北竹溪人福药业有限责任公司 一种去氢表雄酮的合成方法
CN109985047B (zh) 2017-12-29 2021-07-27 广州市赛普特医药科技股份有限公司 5α-雄甾-3β,5,6β-三醇在制备治疗出血性脑卒中药物中的应用
CN109369760B (zh) * 2018-12-18 2021-01-01 湖南科瑞生物制药股份有限公司 一种制备去氢甲基睾丸素的方法
CN109369761B (zh) * 2018-12-18 2021-01-01 湖南科瑞生物制药股份有限公司 一种去氢甲基睾丸素的制备方法
CN113318114B (zh) * 2020-02-28 2023-02-17 广州市赛普特医药科技股份有限公司 小分子化合物在治疗肺上皮细胞损伤和/或血管内皮细胞损伤介导的疾病中的用途
CN114195844B (zh) * 2021-12-29 2023-03-17 湖北武当安泰药业有限公司 一种去氢表雄酮的制备方法
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410516B1 (en) 1986-01-09 2002-06-25 President & Fellows Of Harvard College Nuclear factors associated with transcriptional regulation
US5071773A (en) 1986-10-24 1991-12-10 The Salk Institute For Biological Studies Hormone receptor-related bioassays
US4898694A (en) * 1987-11-25 1990-02-06 Schwartz Arthur G 17-Hydroxy-steroids
WO1995010527A1 (en) * 1993-10-13 1995-04-20 Neurocrine Biosciences, Inc. 3,17-dihydroxy-3,7,16 and/or 17-methyl-androst-5-ene compounds, derivatives thereof, and their use
US6545027B1 (en) 1995-06-07 2003-04-08 Eli Lilly And Company Methods of modulating NF-kB transcription factor
US5989835A (en) 1997-02-27 1999-11-23 Cellomics, Inc. System for cell-based screening
US5753266A (en) * 1996-12-03 1998-05-19 Youssefyeh; Parvin Safflower seed powder compositions for the treatment of rheumatoid based arthritic diseases
US20030083231A1 (en) * 1998-11-24 2003-05-01 Ahlem Clarence N. Blood cell deficiency treatment method
US6667299B1 (en) * 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
AU2005211675B2 (en) * 1999-03-23 2009-09-24 Harbor Biosciences, Inc. Immunomodulatory steroids, in particular the hemihydrate of 16.alpha.-bromoepiandrosterone
EP1422234A3 (en) * 1999-03-23 2010-12-08 Harbor BioSciences, Inc. Immunomodulatory steroids, in particular the hemihydrate of 16.alpha.-bromoepiandrosterone
JP2003506081A (ja) * 1999-08-06 2003-02-18 グラクソ ウェルカム，ソシエダッド アノニマ ＮＦ−κＢ活性化に関与するプロテインキナーゼＣ相互作用性タンパク質
US6864355B1 (en) 2000-05-02 2005-03-08 Yale University Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain
AU7736300A (en) * 1999-09-30 2001-04-30 Hollis-Eden Pharmaceuticals, Inc. Therapeutic treatment of androgen receptor driven conditions
US6593511B1 (en) 2000-05-12 2003-07-15 Bioseek, Inc. Models of chronic and acute inflammatory diseases
EP2135611A1 (en) * 2001-03-01 2009-12-23 Hollis-Eden Pharmaceuticals Inc. Pregn-5-en-20-yne-3,7,17-triol derivatives for use in therapy
WO2002092623A1 (en) 2001-05-11 2002-11-21 Research Development Foundation INHIBITORS OF RECEPTOR ACTIVATOR OF NF-κB AND USES THEREOF
JP2005505285A (ja) * 2001-10-09 2005-02-24 イミュネックス・コーポレーション 哺乳動物ｃ型レクチン
JP2006506445A (ja) * 2002-08-28 2006-02-23 ホリス − イーデン ファーマスーティカルズ、 インコーポレイテッド 治療処置の方法
KR100667123B1 (ko) * 2002-11-07 2007-01-12 파마시아 앤드 업존 캄파니 엘엘씨 Ｃ-7 치환된 5-안드로스텐의 제조 방법
US7884196B2 (en) 2004-10-06 2011-02-08 Oliver Lawless Vaccine composition comprising methylated DNA and immunomodulatory motifs

Also Published As

Publication number Publication date
WO2008039566A3 (en) 2008-11-27
CA2649940A1 (en) 2008-04-03
DK2486924T3 (en) 2019-03-04
WO2008039566A2 (en) 2008-04-03
EP2012773A4 (en) 2010-01-13
AU2007300404B2 (en) 2009-12-17
EP2486924A2 (en) 2012-08-15
JP2012255033A (ja) 2012-12-27
EP2012773A2 (en) 2009-01-14
EA200802167A1 (ru) 2009-04-28
CN103211821A (zh) 2013-07-24
EP2486924B1 (en) 2018-12-26
EP2012773B1 (en) 2012-06-20
JP2009534427A (ja) 2009-09-24
JP5130591B2 (ja) 2013-01-30
DK2012773T3 (da) 2012-09-24
AU2007300404A1 (en) 2008-04-03
PL2486924T3 (pl) 2019-07-31
IL194751A0 (en) 2009-08-03
KR20080112413A (ko) 2008-12-24
ES2710288T3 (es) 2019-04-24
HUE042925T2 (hu) 2019-07-29
EP2486924A3 (en) 2013-01-09
AU2010201023A1 (en) 2010-04-08
AU2010201023B2 (en) 2012-02-09
CA2649940C (en) 2012-08-07
ES2389743T3 (es) 2012-10-31

Similar Documents

Publication Publication Date Title
IL194751A0 (en) Drugs and uses
ZA200810323B (en) Fkbp-l and uses thereof
TWI561237B (en) Substituted dihydropyrazolones and their use
PL2064327T3 (pl) Dbait i ich zastosowania
IL205571A0 (en) 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin
EP1992348A4 (en) PHARMACEUTICAL COMBINATION
ZA200807544B (en) Pseudoinfectious flavivirus and uses thereof
HK1136160A1 (en) Disintegrin variants and pharmaceutical uses thereof
GB0621160D0 (en) Compounds and uses thereof
HK1133552A1 (en) Carboranylporphyrins and uses thereof
IL193700A0 (en) Medicaments and proteins
ZA200806318B (en) Drug combinations
EP2077262A4 (en) IMINOPYRIDINE DERIVATIVES AND THEIR USE
EP2124908A4 (en) CONNECTIONS AND ITS USE
IL197883A0 (en) Combination drug
EP2120563A4 (en) CONNECTIONS AND ITS USES
EP2069371A4 (en) ORGANO ARSENOXIDE COMPOUNDS AND THEIR USE
EP2099459A4 (en) COMPOUNDS AND USES THEREOF
GB0610059D0 (en) Uses and methods
EP2120957A4 (en) COMPOUNDS AND USES THEREOF
GB2444960B (en) Combined pseudoscope and hyperscope
GB0621665D0 (en) Blogmail and podmail
IL196823A0 (en) Tetraarylporphine derivatives and uses thereof
GB0622332D0 (en) Drug
ZA200902756B (en) Combination drug